Difficulty: Medium
Average Score: 89%
Practice
Carbidopa is unable to penetrate the blood-brain barrier, it acts to reduce the peripheral conversion of levodopa to dopamine.
Correct answer
A
Rationale
In the context of lifespan pharmacology, understanding the mechanism of action of medications like Carbidopa is crucial for effective patient care. The correct answer is A) TRUE. Carbidopa does not penetrate the blood-brain barrier, which means it does not exert its effects in the central nervous system. Instead, it acts peripherally to inhibit the enzyme DOPA decarboxylase, which converts levodopa to dopamine outside the blood-brain barrier. This results in more levodopa being available to cross the blood-brain barrier and be converted to dopamine in the brain, where it is needed to alleviate symptoms of Parkinson's disease.
Option B) FALSE is incorrect because it contradicts the established pharmacological knowledge about Carbidopa's mechanism of action. Carbidopa's primary role is to reduce the peripheral conversion of levodopa to dopamine, not to act directly on dopamine receptors in the brain.
Option C) None is incorrect as it does not provide a valid response to the question and does not align with the pharmacological actions of Carbidopa.
Option D) All of the above is incorrect as it is a combination of the previous options and does not logically apply to the question at hand.
Educationally, understanding the pharmacology of medications used in lifespan care is essential for healthcare professionals to make informed decisions about treatment options for patients. Knowing how Carbidopa works in conjunction with levodopa provides a foundation for managing Parkinson's disease and optimizing therapeutic outcomes.
Option B) FALSE is incorrect because it contradicts the established pharmacological knowledge about Carbidopa's mechanism of action. Carbidopa's primary role is to reduce the peripheral conversion of levodopa to dopamine, not to act directly on dopamine receptors in the brain.
Option C) None is incorrect as it does not provide a valid response to the question and does not align with the pharmacological actions of Carbidopa.
Option D) All of the above is incorrect as it is a combination of the previous options and does not logically apply to the question at hand.
Educationally, understanding the pharmacology of medications used in lifespan care is essential for healthcare professionals to make informed decisions about treatment options for patients. Knowing how Carbidopa works in conjunction with levodopa provides a foundation for managing Parkinson's disease and optimizing therapeutic outcomes.